Clinical trial

Atezolizumab in Large Cell Neuroendocrine Carcinoma

NCT06049966

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-11-01

PhasePHASE1

Study timeline

Study start (actual)2019-11-01Date precision: day

Registry last updated2026-07-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Large Cell Neuroendocrine Carcinoma of the Lungunresolved

Interventions

AtezolizumabDRUG · verified · RxNorm: atezolizumab

CarboplatinDRUG · verified · RxNorm: carboplatin

EtoposideDRUG · verified · RxNorm: etoposide

Sponsors & collaborators

Oncology Center of Biochemical Education And Researchlead sponsor

Mapped research locations

AthensGreece2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06049966 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.